Загрузка...

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

BACKGROUND AND AIMS: Chronic hepatitis C (HCV) is a liver disease affecting over 3 million Americans. Liver biopsy is the gold standard for assessing liver fibrosis and is used as a benchmark for initiating treatment, though it is expensive and carries risks of complications. FibroTest is a non-inva...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Liu, Shan, Schwarzinger, Michaël, Carrat, Fabrice, Goldhaber-Fiebert, Jeremy D.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2011
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3229483/
https://ncbi.nlm.nih.gov/pubmed/22164204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0026783
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!